Flo Health is a technology company.
Flo Health has raised $26.0M across 4 funding rounds.
Flo Health has raised $26.0M in total across 4 funding rounds.
Flo Health has raised $26.0M in total across 4 funding rounds.
Flo Health's investors include Balderton Capital, Eight Roads, Flint Capital, Mangrove Capital Partners, Zachary Hargreaves, Sergey Gonchar.
Flo Health is a technology company that develops Flo, a leading AI-driven women's health app designed to support users throughout their reproductive health journey—from menstruation and ovulation tracking to pregnancy, early motherhood, and menopause. Serving over 75 million monthly active users globally, Flo provides personalized health insights, cycle predictions, and expert-backed content to empower women and those who menstruate to better understand and manage their health. The app addresses key problems such as irregular cycles, fertility planning, and pregnancy support, leveraging advanced AI and data science to deliver tailored recommendations and predictive health alerts. Flo has demonstrated strong growth momentum, becoming the #1 OB-GYN-recommended app in its category and the first European femtech unicorn following significant investment in 2024[1][2][3][4].
Founded in 2015 by a team focused on female health, Flo emerged from the need for a comprehensive, personalized digital companion for women's reproductive health. The founders recognized the gap in accessible, data-driven health tools for women and built Flo to fill that void. Early traction came from rapid user adoption, reaching 1 million installs by 2016 and 10 million monthly users by 2017, with machine learning integrated early on to improve prediction accuracy. Partnerships with organizations like the UNFPA and continuous innovation in AI-powered features such as the "Ask Flo" health assistant have been pivotal moments in its evolution[2][5].
Flo rides the growing trend of personalized digital health and femtech innovation, leveraging big data and AI to transform women's health management. The timing is critical as awareness and demand for female-centric health solutions rise globally, supported by advances in AI and mobile technology. Market forces such as increasing smartphone penetration, growing health consciousness, and the shift toward preventive care favor Flo's model. By setting a high standard for data-driven, user-centric femtech, Flo influences the broader ecosystem by demonstrating how AI can enhance health outcomes and user engagement in a traditionally underserved segment[2][4].
Flo is poised to deepen its AI capabilities and expand its health assistant features, potentially integrating more advanced predictive analytics and personalized interventions. Trends shaping its journey include the rise of generative AI, increased focus on mental and holistic health, and expanding global access to digital health tools. As Flo continues to scale and innovate, its influence may extend beyond femtech into broader women's health and wellness markets, reinforcing its role as a critical health companion. Its commitment to accessibility and medical rigor positions it well to maintain leadership amid growing competition and evolving user expectations[1][2][4].
Flo Health has raised $26.0M across 4 funding rounds. Most recently, it raised $8.0M Series A in May 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2019 | $8.0M Series A | Balderton Capital, Eight Roads, Flint Capital, Mangrove Capital Partners, Zachary Hargreaves | |
| Oct 1, 2018 | $12.0M Series A | Flint Capital, Mangrove Capital Partners, Sergey Gonchar, Zachary Hargreaves | |
| Aug 1, 2017 | $5.0M Series A | Flint Capital | |
| Dec 1, 2016 | $1.0M Seed | Flint Capital |